BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36096062)

  • 1. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
    Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
    Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition-inflammation marker enhances prognostic value to ECOG performance status in overweight or obese patients with cancer.
    Zhang X; Zhang Q; Tang M; Zhang KP; Zhang XW; Song MM; Ruan GT; Sun Q; Li W; Xu HX; Cong MH; Deng L; Shi HP
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):109-119. PubMed ID: 35589385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
    Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
    Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study.
    Zhang KP; Zhang X; Zhang Q; Ruan GT; Song MM; Xie HL; Zhang HY; Li XR; Yang M; Liu YY; Li QQ; Ge YZ; Liu XY; Lin SQ; Li W; Xu HX; Deng L; Shi HP
    J Nutr Health Aging; 2022; 26(9):847-855. PubMed ID: 36156676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery.
    Nakamura Y; Imada A; Fukugaki A; Kanto S; Yamaura T; Kinjo Y; Kuroda N
    Clin Nutr ESPEN; 2022 Jun; 49():417-424. PubMed ID: 35623847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?
    Ekinci F; Sarı D; Çelik C; Dirican A; Erdoğan AP; Gökse G
    Gulf J Oncolog; 2021 May; 1(36):45-52. PubMed ID: 35017135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive prognostic effects of systemic inflammation and Insulin resistance in women with breast cancer with different BMI: a prospective multicenter cohort.
    Ruan GT; Xie HL; Hu CL; Liu CA; Zhang HY; Zhang Q; Wang ZW; Zhang X; Ge YZ; Lin SQ; Tang M; Song MM; Zhang XW; Liu XY; Zhang KP; Yang M; Yu KY; Wang KH; Hu W; Deng L; Cong MH; Shi HP
    Sci Rep; 2023 Mar; 13(1):4303. PubMed ID: 36922570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
    Eren T
    ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.
    Rocha BMM; Dolan RD; Paiva CE; McGovern J; Paiva BSR; Preto DD; McMillan DC; Maia YCP; Laird BJ
    J Pain Symptom Manage; 2023 Apr; 65(4):348-357. PubMed ID: 36493981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.
    Dolan RD; Laird BJA; Klepstad P; Kaasa S; Horgan PG; Paulsen Ø; McMillan DC
    Medicine (Baltimore); 2019 Sep; 98(37):e17019. PubMed ID: 31517821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
    Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
    Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
    Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
    BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab.
    Araki T; Tateishi K; Sonehara K; Hirota S; Komatsu M; Yamamoto M; Kanda S; Kuraishi H; Hanaoka M; Koizumi T
    Thorac Cancer; 2021 Mar; 12(5):603-612. PubMed ID: 33434414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
    Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
    Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
    Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
    Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte-C-reactive protein ratio with calf circumference could better predict survival of patients with non-metastatic cancer.
    Liu XY; Zhang X; Zhang Q; Ruan GT; Xie HL; Liu T; Song MM; Ge YZ; Deng L; Shi HP
    Sci Rep; 2023 May; 13(1):7217. PubMed ID: 37137949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.